Loading stock data…
IDEXX Laboratories, Inc. (IDXX)
$535.38+6.09 (+1.15%)
Pre-Market$530.72-4.66 (-0.87%)· Last close Sep 4
IDEXX Laboratories, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
IDEXX Laboratories, Inc. in the Healthcare sector is trading at $535.38 with a market capitalization of $43.4B. Wall Street consensus targets $698.92 (13 analysts), implying a +30.5% move over the next 12 months. The stock is currently near its 52-week low of $518.55, remaining 11.8% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +30.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $1.14B↑ | $1.09B↓ | $1.11B↓ | $1.11B |
| Gross Profit | — | $722.74M↑ | $658.11M↓ | $683.35M↓ | $694.73M |
| Operating Income | — | $362.59M↑ | $315.61M↓ | $354.85M↓ | $373.05M |
| Net Income | — | $278.45M↑ | $248.19M↓ | $274.61M↓ | $293.99M |
Peer Comparison
JNJUNHPFE
Fundamentals
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Co...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$43.41B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
39.84
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.54
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
51.49%
Volume
Today's trading volume
407,845
Recent News
Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?
IDEXX Laboratories has struggled to keep pace with the broader market over the past year, but Wall Street still sees plenty of room for the stock to recover, with analysts maintaining a moderately bullish outlook on its prospects.
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?
IDXX's CAG diagnostics and cloud software growth support recurring revenues, while FX exposure and distributor inventory swings remain key risks.
Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Focused Growth Fund”. A copy of the letter can be downloaded here. In the second quarter, the Baron Focused Growth Fund achieved a 13.26% gain, still trailing the Russell 2500 Growth Index’s 24.02% return. The underperformance was driven by ongoing concerns […]
IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve
IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.